-
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Friday, September 8, 2023 - 8:42am | 1781Read More...Swedish biopharma Calliditas Therapeutics AB (NASDAQ:CALT) is making significant strides in addressing rare kidney diseases. In a recent interview with Benzinga, the company’s CEO, Renee Aguiar-Lucander, provided valuable insights on various aspects of its work. Tarpeyo – A Unique...
